Drug makers Dr Reddy's Laboratories, Sun Pharma and Aurobindo Pharma are recalling products in the US market due to manufacturing issues, as per the latest Enforcement Report of the US Food and Drug Administration (USFDA). New Jersey-based Dr Reddy's Laboratories, Inc., is recalling Javygtor (sapropterin dihydrochloride) Powder for Oral Solution (100mg) being a "Sub-potent Drug", USFDA stated. The USFDA said the drug maker initiated the Class I recall in the US on April 8 this year. As per the US health regulator, a Class I recall pertains to defective products that can cause serious health problems. The US generic drug market, estimated to be around $115.2 billion in 2019, is the largest market for pharmaceutical products.

Source: The Hindu May 19, 2024 18:15 UTC